Financing for Concert Pharmaceuticals

CoNCERT Pharmaceuticals, Inc. Raises $37 Million in Series C Financing
CoNCERT Pharmaceuticals, Inc., announced the closing of a $37 million Series C financing today. The Company intends to use the proceeds to further advance its deuterium chemistry platform and product pipeline. The financing was led by a leading public equity institutional investor and included participation [...]